Pricing Log in Create free account

TuHURA Biosciences, Inc. (HURA) vs NRx Pharmaceuticals, Inc. (NRXP)

TuHURA Biosciences, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($102.6M and $98.3M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −691.8%) and the lower return on invested capital (−74.2% vs 0.00%). Across the 13 metrics below, NRx Pharmaceuticals, Inc. leads on 7 and TuHURA Biosciences, Inc. on 6.

Valuation

Metric HURA NRXP Biotechnology median
P/E n/m n/m 10.60
P/S n/m 25.96 9.40
P/B 5.72 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 19.69 9.02
Earnings yield (33.13%) (23.50%) (32.88%)
Free cash flow yield (28.71%) (23.46%) (23.13%)

Profitability

Metric HURA NRXP Biotechnology median
Gross margin 0.00% 46.64% 68.51%
Operating margin 0.00% (586.15%) 0.00%
Net margin 0.00% (691.78%) 0.00%
Free cash flow margin 0.00% (609.02%) 0.00%
Return on equity (163.84%) 131.22% (51.96%)
Return on assets (92.31%) (120.41%) (46.06%)
Return on invested capital (74.20%) 0.00% 0.00%

Growth

Metric HURA NRXP Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 47.93% 43.22% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HURA NRXP Biotechnology median
Debt to equity 0.47 (2.42) 0.00
Current ratio 0.18 0.86 4.97
Net debt to EBITDA 0.12 0.48 1.01

Dividend

Metric HURA NRXP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HURA NRXP Biotechnology median
Market cap 102.60m 98.28m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack